Responses
Clinical/translational cancer immunotherapy
Original research
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Compose a Response to This Article
Other responses
No responses have been published for this article.
